OCDX Insider Trading Activity and SEC Form 4 Filings
OCDX insider trading summary
No open-market insider purchases or sales of Ortho Clinical Diagnostics Holdings plc (OCDX) have been reported on SEC Form 4 in the past 12 months.
Latest OCDX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 4, 2022 | Michael A. Schlesinger | EVP, GC and Secretary | Sell | $1.7M (88,043 @ $18.77) |
| Jan 3, 2022 | Michael A. Schlesinger | EVP, GC and Secretary | Sell | $2.7M (130,000 @ $21.09) |
| Jan 3, 2022 | Christopher M Smith | Chairman and CEO | Sell | $2.1M (100,000 @ $21.10) |
| Oct 15, 2021 | Michael A. Schlesinger | EVP, GC and Secretary | Sell | $1.5M (75,464 @ $19.73) |
| Sep 14, 2021 | TC Group Cayman Investment Holdings, L.P. | 10% Owner | Sell | $425.0M (25,300,000 @ $16.80) |
| Sep 14, 2021 | Carlyle Group Inc. | 10% Owner | Sell | $425.0M (25,300,000 @ $16.80) |
| Sep 14, 2021 | TC Group Cayman Investment Holdings Sub L.P. | 10% Owner | Sell | $425.0M (25,300,000 @ $16.80) |
| Sep 14, 2021 | Carlyle Holdings II GP L.L.C. | 10% Owner | Sell | $425.0M (25,300,000 @ $16.80) |
| Sep 14, 2021 | CG Subsidiary Holdings L.L.C. | 10% Owner | Sell | $425.0M (25,300,000 @ $16.80) |
| Sep 14, 2021 | TC Group VI Cayman, L.L.C. | 10% Owner | Sell | $425.0M (25,300,000 @ $16.80) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.